Login with email

New to HotPause Health?

Sign up with email

Password Requirements:

  • 8 or more characters
  • 1 uppercase and 1 lowercase letter
  • 1 number
  • 1 of these characters @$!%*?& (no other characters)

Sign up with Google

Reset Password

Enter your email and we will send you a reset link.

Remove Account

Are you sure you want to remove your account?

Deleting your account will not remove the content that you have contributed to HotPause Health.

Log in again to confirm:

Share a Product

Drag image here

or

Links
Product Categories

Share a Doctor

Links
Doctor Categories

Edit Comment

Post a Topic

Categories

    Welcome to HotPause Health!

    We are happy to have you as part of our community.

    Please check your email for a verification link

    *It may take a few minutes for the email to arrive.
    **Be sure to check your spam/junk folder.

    NON-HORMONAL TREATMENT

    Flibanserin (Addyi)

    Addyi, is an FDA-approved medication specifically designed to treat Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women.

    *Content reviewed by HotPause Health Medical Advisor & Doctor of Pharmacy Audrey Hou, PharmD, CMPP

    Generically known as flibanserin, Addyi, is an FDA-approved medication specifically designed to treat Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women. HSDD is characterized by a low sexual desire that is troubling to the individual, not attributable to existing medical or mental health issues, relationship problems, medication, or other drug use. HSDD is often experienced by an absence of sexual fantasies, thoughts, and/or desire for or receptivity to sexual activity.

    How Addyi Works

    Addyi is a non-hormonal medication that works by affecting the balance of certain neurotransmitters in the brain involved in sexual desire and inhibition. The exact mechanism is not fully understood, but it is thought to enhance the factors that promote sexual desire while inhibiting those that dampen it.

    Who Should Use Addyi

    Addyi is prescribed for women who have not yet undergone menopause and are experiencing low sexual desire not related to an existing medical condition, relationship issues, or as a side effect of other medications. It is important to note that Addyi is not suitable for treating HSDD in post-menopausal women or to enhance sexual performance.

    Potential Benefits of Addyi for Menopause

    • Many women start to experience improvements in their HSDD symptoms, such as increased sexual desire, reduced distress, and an increase in satisfying sexual events, as early as four weeks after beginning treatment with Addyi. However, it may take longer for some women to notice improvements. If no improvement is observed within eight weeks, discontinuation of the medication is recommended.

    Best for treating:

    Usage and Considerations

    Addyi is taken once daily at bedtime. This consistent daily dosing helps manage the symptoms of HSDD effectively. It is not an on-demand medication, and skipping doses can affect its efficacy. If a dose is missed, it should be skipped and the next dose taken at the usual time the following night.

    Side Effects and Considerations

    Common side effects of Addyi include:

    • Dizziness
    • Difficulty falling asleep or staying asleep
    • Nausea
    • Dry mouth
    • Tiredness

    Due to its interaction with certain medications, Addyi can significantly increase in blood levels, leading to severe low blood pressure and fainting, particularly if mixed with alcohol. It is critical to inform healthcare providers about all medications being taken, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Specific medications to avoid while on Addyi include certain antibiotics, antifungals, antivirals, and drugs used for treating high blood pressure and chest pain. Consult your pharmacist for a comprehensive review.

    Addyi should only be used by the patient group for which it is indicated, and it must be prescribed and used under the guidance of a healthcare provider familiar with its use and potential risks. Prior to starting treatment, a comprehensive medical evaluation should be conducted to confirm the diagnosis of HSDD and to check for any health conditions or medications that might contraindicate its use.

    Conclusion

    Addyi represents a significant advancement in the treatment of Hypoactive Sexual Desire Disorder for premenopausal women. By addressing the complex neurochemical factors influencing sexual desire, Addyi can help improve the quality of life for women experiencing HSDD. Like all medications, it is essential to use Addyi under the strict supervision of a healthcare provider to maximize benefits and minimize risks.

    Reference:

    Addyi [package insert]. Raleigh, NC: Sprout Pharmaceuticals, Inc.; 2015.

    The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.
    © 2024 HotPause Health, Inc. Privacy Policy Terms of Use Cookie Policy Community Guidelines